ライフサイエンスコーパス: subject with

1 ere enrolled resulting in 904 nonduplicative subjects with 1808 blood cultures.

2 Fifteen subjects with 2 posterior implants and corresponding con

3 ond 12 months versus placebo was similar for subjects with (2.5% vs. 4.5%; hazard ratio: 0.55; 95% co

4 In our cohort of 1472 subjects with 22q11.2DS, a total of 62% (n=906) have con

5 samples from 329 psychiatrically phenotyped subjects with 22q11.2DS.

6 y Cox proportional hazard model and compared subjects with 3 to 4 and subjects with 5 to 7 ideal metr

7 model and compared subjects with 3 to 4 and subjects with 5 to 7 ideal metrics with those with 0 to

8 We included 574 subjects with 9776 twenty-four-hour urine samples.

9 Subjects with a clinical diagnosis of Alzheimer disease,

10 ioflupane images from 3 trials that included subjects with a clinical diagnosis of PS, non-PS (mainly

11 analyzed cross-sectional data from 1932 case subjects with a first nonfatal MI and 2055 population-ba

12 ated from primary immune blood cells: (i) 14 subjects with a history of infection with West Nile viru

13 Subjects with a personal medical history of cancer or ca

14 Probing plasma from 500 subjects with a smaller subset of 2000 resynthesized ssO

15 We find that after familiarizing subjects with a spatial sequence, flashing only the star

16 cape of BCAs at nucleotide resolution in 273 subjects with a spectrum of congenital anomalies.

17 odels and in translational studies involving subjects with active HSV-2-specific immune responses.

18 down-regulated in colonic tissues from human subjects with active ulcerative colitis or Crohn's disea

19 Only subjects with "active asthma" (symptoms or medication in

20 serum chloride and clinical outcomes in 7195 subjects with acute myocardial infarction complicated by

21 Consecutive subjects with acute respiratory distress syndrome.

22 Controls were subjects with acute respiratory illness testing negative

23 profiled proteomic signatures in serum from subjects with AD, PS, and CD compared with healthy contr

24 Eight subjects with advanced, treatment-experienced wet AMD we

25 cohort was then enriched for all additional subjects with adverse outcomes (death, dialysis-dependen

26 of ILC2s during nasal allergen challenge in subjects with allergic rhinitis using novel noninvasive

27 In subjects with alternating strabismus, either eye can be

28 itive impairment, and this was compared with subjects with Alzheimer's disease.

29 From an evolutionary perspective, subjects with an effective immune response against helmi

30 We selected adult subjects with an estimated glomerular filtration rate >6

31 upregulation of CD200R in lesional skin from subjects with an extrinsic AD phenotype compared to heal

32 yanins and degradants in the plasma/urine of subjects with an intact gut.

33 Among subjects with anatomic complexity, those with DAPT score

34 ent (KR) associated with meniscal surgery in subjects with and those without a reported history of pr

35 ace narrowing (JSN) progression evaluated in subjects with and those without underlying osteoarthriti

36 s a variety of in vitro and in vivo tests in subjects with and without T2D, identifies the mechanisms

37 association with pathogenic phenotypes in 17 subjects with apparently balanced chromosomal abnormalit

38 In contrast, spouses of subjects with AS were only slightly more likely to be di

39 Subjects with asthma and the AA/AG genotypes had a 5% de

40 f self-identified African American and white subjects with asthma enrolled in clinical trials conduct

41 RSV infection of BECs from subjects with asthma, compared with uninfected BECs from

42 h asthma, compared with uninfected BECs from subjects with asthma, led to a significant increase in e

43 significantly different frequencies in 5,724 subjects with at least one invasive tumor and 1,943 subj

44 C2s and granulocytes to the upper airways of subjects with atopy and healthy subjects after allergen

45 After an allergen challenge, subjects with atopy displayed rapid induction of upper a

46 e density of neuropeptide Y+ neurons between subjects with autism and controls.

47 he CSF level of this 25-kDa CTF is higher in subjects with autosomal dominant AD linked to PSEN1 muta

48 Peripheral blood gene expression to identify subjects with bacterial infection is a promising strateg

49 Recently, subjects with Barber-Say and Ablepharon-Macrostomia synd

50 uld interpret (18)F-fluciclovine images from subjects with biochemically recurrent prostate cancer wi

51 Inclusion criteria were studies of subjects with biopsy-confirmed celiac disease, follow-up

52 re numerous in subjects with SZ, but rare in subjects with bipolar disorder and major depressive diso

53 After adjusting for confounding factors, subjects with birth weight <2500 g were at a significant

54 ficantly increased CVD risk when compared to subjects with birth weight between 2500-3999 g (OR 2.47,

55 , 12 subjects with moderate to severe PS, 10 subjects with both AD and CD, and 10 HC with no history

56 Among the subjects with BRVO and CRVO, 37.25% and 50% had low visi

57 ria settings as follows: 1) the exclusion of subjects with C-reactive protein (CRP) concentrations >5

58 ficial siderosis-positive, but cSAH-negative subjects with CAA (76% vs 30%; p<0.0001).

59 Eight human subjects with cancer and eight healthy volunteers underw

60 Subjects with cardiovascular disease were 2.33 times mor

61 m 20 subjects with moderate to severe AD, 10 subjects with CD, 12 subjects with moderate to severe PS

62 anti-TG2A and celiac disease indicates that subjects with celiac disease might have increased intest

63 ted that disease risk might be modifiable in subjects with certain gene variants.

64 nalysis in human heart samples obtained from subjects with Chagas disease who underwent heart transpl

65 ralizing antibodies (bnAbs) and sera from 30 subjects with chronic clade C infections.

66 Fourteen subjects with chronic hemiplegia participated in the stu

67 patients and in a second sample of 248 case subjects with chronic psychosis.

68 We hypothesized that subjects with CKD have increased arterial and cellular i

69 keletal muscle, and plasma metabolomics from subjects with classical and early-onset forms of type 2

70 inflammation and neurological damage in HIV- subjects with CNS cryptococcosis may help gauge disease

71 er 2006, fewer eyes and fewer >/=80-year-old subjects with CNV were visually impaired (P = 0.016).

72 nalysis of (18)F-FDG PET data in 5 groups of subjects with cognitive states ranging from normal aging

73 A total of 11,532 subjects with complete genotype and computed tomography

74 We analyzed 8,034 subjects with complete inspiratory and expiratory comput

75 Here, we presented subjects with comprehensible and incomprehensible accele

76 variate hazard ratios increased from 1.2 for subjects with concentrations of 0-2 mug fHb/g to 8.2 for

77 h concentrations of 0-2 mug fHb/g to 8.2 for subjects with concentrations of 8-10 mug fHb/g (P < .001

78 Ten subjects with confirmed ADA-deficient SCID and no availa

79 In subjects with COPD, exacerbations were associated with e

80 One hundred seventy-nine subjects with corneal ectasia after previous refractive

81 th ARHGEF18 mutations resembled that seen in subjects with CRB1 mutations.

82 ifference in NK cell activity between the 23 subjects with CRC (based on pathology analysis) and the

83 The NK cell activity test identified subjects with CRC with 87.0% sensitivity, 60.8% specific

84 we found significantly smaller hippocampi in subjects with current PTSD compared with trauma-exposed

85 Results Of 415 subjects with DCIS who underwent preoperative MR imaging

86 IP-10 levels were significantly higher in subjects with detectable VL (108.2 pg/mL) as compared to

87 ion at the FGF21 locus was elevated in human subjects with diabetes and correlated negatively with ex

88 thout diabetes, hazard ratio (HR) of TKR for subjects with diabetes was 0.63 [95% confidence interval

89 in is increased in renal biopsies from human subjects with diabetic nephropathy.

90 n and microbiota-metabolite relationships in subjects with different body mass index and individuals

91 t motion patterns and B0 field variations in subjects with different predispositions for head movemen

92 n the left hemisphere was relatively spared, subjects with disorganized community structure had signi

93 Characterizing subgroups of at risk subjects, with diverse prognostic outcomes, may provide

94 In subjects with DME, sustained intraocular delivery of FAc

95 ell frequencies were significantly higher in subjects with Down syndrome, whereas their inhibitory re

96 e progression in both preclinical models and subjects with Duchenne muscular dystrophy (DMD).

97 Hepatic DPP4 expression is elevated in subjects with ectopic fat accumulation in the liver.

98 e extracted from exome-sequencing data of 42 subjects with EE and no previous genetic diagnosis.

99 the 4 parameters by echocardiography in 100 subjects with EF ranging from 16% to 72% and comparing m

100 associated with all-cause mortality only in subjects with eGFR <90 mL/min/1.73 m(2) [adjusted HR:1.1

101 d a sputum eosinophil 2% cut point to define subjects with either an eosinophilic (>/=2%) or noneosin

102 r Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).

103 pronounced ILC2 recruitment was observed in subjects with elevated serum IgE and airway eosinophilia

104 Analysis of human subjects with essential hypertension showed 2.6-fold inc

105 pediatric and adult asthma cases and control subjects with European American and African American anc

106 ary for survival of EVI1-expressing cells in subjects with EVI1-positive AML.

107 As a consequence, in subjects with F0-F2 fibrosis, the rates of false-positiv

108 The Baltimore group had 28 subjects with falls, 32 frail subjects, and 5 deaths.

109 months post-procedure was the percentage of subjects with FEV1 improvement from baseline of 12% or g

110 Subjects with first-time AF diagnosed from 1997 to 2012

111 e -1.47, P=.002) were underrepresented among subjects with food sensitization.

112 ssure pulsatility significantly decreased in subjects with functional improvement, whereas no change

113 improvements in radiographic lung disease in subjects with G551D-CFTR mutations.

114 Only 43 of the 85 subjects with germline mutations associated with a hered

115 Similar analyses were performed to classify subjects with good glycemic improvements.

116 In particular, in subjects with >/=5 metrics at the ideal level (compared

117 mpared with those of 50 age- and sex-matched subjects with HbAA as controls.

118 METHODS AND We randomized 12 subjects with heart failure with preserved ejection frac

119 In 514 subjects with HF, there were 98 (19.1%) all-cause deaths

120 ial stiffness at rest and during exercise in subjects with HFpEF and hypertensive control subjects to

121 to exclude disease (</=125 pg/mL) in 18% of subjects with HFpEF.

122 All subjects with high airway mucosal CCL26 expression and m

123 Results:(18)F-FDG uptake identified subjects with high and low levels of cold-activated BAT

124 to detect salivary cortisol levels in human subjects with high and low risks for obstructive sleep a

125 The results showed that the female subjects with high frequent genotype in GAL3ST4 had a fi

126 d a 10-fold higher risk of CRC compared with subjects with high NK cell activity.

127 sample of 34 MDD and 26 healthy control (HC) subjects, with high-resolution magnetic resonance imagin

128 Additionally, subjects with higher AQ scores spent more time than low

129 The percentage of subjects with higher education did not significantly dec

130 Subjects with HIV had smaller transaminase reductions af

131 here was also an increased risk of RVO among subjects with hypermetropia, those with pseudophakia and

132 female; P = 0.766) between clinically normal subjects with hyperreflective ONHD bands and those witho

133 METHODS AND We studied 260 subjects with hypertension and 19 normotensive age- and

134 Overall, subjects with hypertension and increasing age were more

135 CI: 7.1, 83.4; P = .020), and hypertension (subjects with hypertension vs those without hypertension

136 ing is upregulated in fibroblasts from human subjects with idiopathic pulmonary fibrosis.

137 +/- 4 and 45 +/- 4 g glucosuria on day 2 in subjects with IFG and NFG, respectively, and the glucosu

138 with normal fasting glucose (NFG) and eight subjects with IFG received empagliflozin (25 mg/day) for

139 liflozin enhanced beta-cell function only in subjects with IFG.

140 Test-retest reproducibility was higher in subjects with immediate centrifugation of blood samples.

141 FPG) concentration and beta-cell function in subjects with impaired fasting glucose (IFG).

142 ostchallenge glucagon levels are observed in subjects with impaired glucose tolerance (IGT).

143 Subjects with improvement on therapy displayed higher ao

144 s with at least one invasive tumor and 1,943 subjects with in situ tumors only.

145 ns (necrolytic migratory erythema), while in subjects with inactivating mutations of the glucagon rec

146 Subjects with incident AF had a 3.5-fold risk of death i

147 Modulation lowered portal pressure in 68% of subjects with inconsistent effects on hepatic arterial a

148 lapsing-remitting males (RRMS) and female MS subjects, with increased levels of CD74 in females vs. m

149 healthy volunteers and eight severely obese subjects with insulin resistance were studied.

150 autopsy from the parietal cortex of 39 human subjects with intact cognition.

151 In subjects with intermediate AMD, choroidal thickness and

152 ly sensitive, identifying only 34% to 60% of subjects with invasively proven HFpEF on the basis of re

153 ulated between patients with SAR and control subjects, with inverse abundance dynamics during the tra

154 imary goal for reducing myocardial injury in subjects with ischemic heart disease.

155 Through whole-exome sequencing in subjects with Joubert syndrome, we identified four child

156 Subjects with knee SxOA were identified if at least one

157 s), we profiled the T cell repertoire of 666 subjects with known cytomegalovirus (CMV) serostatus by

158 number of mucosal lesions and the number of subjects with large erosions and/or ulcers after 14 days

159 y antigens expressed later, that distinguish subjects with latent (LTBI), pulmonary (PTB) or extrapul

160 CVD risk was highest in subjects with LBW and HWC (+LBW/+HWC), OR 4.74 (95%CI, 1

161 cts models (to account for relatedness among subjects) with linear splines (spline 1: ESI </=3.7 g/da

162 In subjects with longitudinal MRI and cognitive data (n = 5

163 lls/mm(3)) compared with a minority (36%) of subjects with low airway mucosal CCL26 expression.

164 sm Quotient (AQ) scores cooperated less than subjects with low AQ scores with the ToM agents.

165 Still, BAT could diagnose subjects with low basophil number in contrast to HR.

166 Subjects with low NK cell activity had a 10-fold higher

167 Subjects with lower rates of adverse reactions, regardle

168 e Acetonide with Intravitreal Aflibercept in Subjects with Macular Edema Due to Retinal Vein Occlusio

169 hosis as well as age-matched healthy control subjects with magnetic resonance spectroscopy (MRS).

170 es changes in brain bioenergetic function in subjects with major depression.

171 lder control subjects, patients with PD, and subjects with MCI demonstrated 1.5, 2, and 2.5 times str

172 Results Three patients with PD and four subjects with MCI were excluded because of excessive hea

173 erformed a retrospective cohort study of 172 subjects with MDR/extensively drug-resistant TB subjects

174 Among five subjects with measurable tumors, increased (18)F-FTT upt

175 Recently, the global efforts to collect subjects with Mendelian disorders, to better define the

176 one morphogenetic protein-9(BMP-9) levels in subjects with Metabolic Syndrome (MetS) and examine the

177 During 2012-2013, 175 subjects with MetS and 226 healthy controls underwent EC

178 Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO O

179 Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO O

180 tudinal outcomes and biomarker data from 562 subjects with mild cognitive impairment (MCI) from two n

181 etic resonance (MR) spectroscopic imaging in subjects with mild cognitive impairment (MCI), patients

182 for a scientific commentary on this article.Subjects with mild cognitive impairment associated with

183 ar amyloid load at baseline and follow-up in subjects with mild cognitive impairment, and this was co

184 Whether exacerbations in subjects with mild COPD or similar acute respiratory eve

185 Even in subjects with mild steroid-naive asthma, differences in

186 two prospective cohort studies that enrolled subjects with mild to moderate post-bronchodilator airfl

187 Sera from 20 subjects with moderate to severe AD, 10 subjects with CD

188 ial biopsies and epithelial brushings of 107 subjects with moderate to severe asthma were annotated b

189 derate to severe AD, 10 subjects with CD, 12 subjects with moderate to severe PS, 10 subjects with bo

190 bo-controlled withdrawal study that included subjects with moderate-to-severe persistent asthma recei

191 A substantial IOP reduction was seen in subjects with more advanced glaucoma suggesting that the

192 Enrolled subjects with more complex target lesions had higher rat

193 We analyzed subjects with more than 4 semi-annual follow-up visits (

194 resection material from a separate group of subjects with (n = 11) or without (n = 11) COPD was coll

195 We evaluated a Discovery Cohort of 2876 AD subjects with (N=1761) or without psychosis (N=1115).

196 212, p = 0.94), but correlated positively in subjects with NAFLD (n = 105, p = 0.0005).

197 We therefore measured the AA profile of 44 subjects with NAFLD without diabetes and who had a liver

198 Thus, we evaluated a) if subjects with NAFLD without obesity (NAFLD-NO) compared

199 The nine CMS subjects with neurological deterioration showed diffuse

200 sma C-peptide response remained unchanged in subjects with NFG.

201 ed unchanged (95 +/- 2 to 94 +/- 2 mg/dL) in subjects with NFG.

202 obese subjects with NGT and IGT versus lean subjects with NGT (8.0 +/- 1.1 and 9.2 +/- 0.7 vs. 4.1 +

203 ting Adipo-IR was increased twofold in obese subjects with NGT and IGT versus lean subjects with NGT

204 se tissue IR [Adipo-IR]) in a large group of subjects with NGT, impaired glucose tolerance (IGT), and

205 Subjects with no preexisting immunity to DENV developed

206 eceptor binding was positively correlated in subjects with no report of ELA (R(2)=0.32, p<0.05).

207 and DeltaSUVr were minimal in Abeta control subjects with no specific flortaucipir F 18 uptake (SUVr

208 Inadvertent inclusion of subjects with nonalcoholic fatty liver disease (NAFLD) a

209 Lung inflammation in tissue from subjects with nondiseased lungs donated for lung transpl

210 Compared with both subjects with nonobese HFpEF and control subjects, subje

211 Stented subjects with nonvalvular atrial fibrillation (n=2124) w

212 oward visual targets almost as gracefully as subjects with normal binocular alignment.

213 ive impairment and AD patients compared with subjects with normal cognition.

214 ratoconus in the fellow eye were compared to subjects with normal eyes.

215 Eight subjects with normal fasting glucose (NFG) and eight sub

216 ompliant prospective study, 158 subjects (43 subjects with normal findings) were enrolled at four ins

217 x increased significantly in IFG, but not in subjects with normal glucose tolerance.

218 tients (n = 97, age 6-71 years) with CHM and subjects with normal vision (n = 44; ages 10-50 years) w

219 Subjects with obese HFpEF (body mass index >/=35 kg/m(2)

220 ts with nonobese HFpEF and control subjects, subjects with obese HFpEF displayed increased plasma vol

221 structure, function, and reserve capacity in subjects with obese HFpEF, those with nonobese HFpEF, an

222 ma AA concentrations were observed mainly in subjects with obesity and NAFLD, likely as a consequence

223 Here we assess decisional impulsivity in subjects with obsessive compulsive disorder who have und

224 stimulation shifts evidence accumulation in subjects with obsessive-compulsive disorder towards a fu

225 However, behavioural experiments on subjects with only rod function reveals that these indiv

226 zed associations between PRM(FSA) and age in subjects with or without airflow obstruction.

227 Subjects with or without Gag P2/NC CS mutations showed n

228 Among subjects with paired testing, the percent predicted maxi

229 , increased (18)F-FTT uptake was seen in one subject with pancreatic adenocarcinoma and another with

230 ajor problems that contribute to falls among subjects with Parkinson's disease (PD).

231 ealthy young subjects and a group of elderly subjects with Parkinson's disease using an event-related

232 However, of 69 subjects with PDFF values less than 5.0% (negative resul

233 All 25 subjects with PDFF values of 5.0% or more had steatosis

234 s determined at week 12, after which group 2 subjects with persistent edema were crossed over to PA q

235 1.42-fold excess relative risk of cancer in subjects with PIDD compared with the age-adjusted SEER p

236 Excess incidence of cancer occurred in subjects with PIDD.

237 o significant increase in these diagnoses in subjects with PIDD.

238 Subjects with plaque >2 mm thick underwent DCE-MRI, and

239 nally in nine chronically infected untreated subjects with plasma viremia of <3,000 RNA copies/ml ove

240 walking) for CNV breakpoint sequencing in 49 subjects with PMD-associated CNVs.

241 Five subjects with posterior cortical atrophy, 4 subjects wit

242 Subjects with postsurgical ME stratified into post-catar

243 Subjects with prediabetes had an increased risk for caro

244 Thus, subjects with prediabetes show early signs of subclinica

245 loss at three time points over 24 months in subjects with premanifest Huntington's disease relative

246 all and site-specific incidence of cancer in subjects with primary immunodeficiency diseases (PIDD) e

247 Human subjects with pseudohypoaldosteronism-1 because of loss-

248 sing whole-exome sequence data from 262 case subjects with pulmonary fibrosis and 4,141 control subje

249 To examine a large cohort of subjects with punctate inner choroidopathy (PIC) looking

250 ditionally, there was a higher risk of KR in subjects with radiographic KL grade of less than 2 (adju

251 sulitic lesions in biopsy specimens from six subjects with recent-onset type 1 diabetes (T1D) and six

252 Serial whole-body PET scans of 5 subjects with recently diagnosed thyroid cancer were acq

253 Our analysis excluded subjects with refractory celiac disease, undergoing glut

254 recordings of 48 convulsive seizures from 48 subjects with refractory focal epilepsy (20 females, age

255 conducted whole-exome sequencing in 202 case subjects with RHD and identified diagnostic mutations in

256 determined the gait parameters of 20 healthy subjects with right-foot preference during treadmill wal

257 ial (BPND) was measured in 14 off-medication subjects with SCH and 14 matched HCs at baseline and aft

258 iance, F1,26 = 1.9, p = .18) between HCs and subjects with SCH.

259 ased amphetamine-induced dopamine release in subjects with schizophrenia (SCH) relative to healthy co

260 ep layer 3 of the primary auditory cortex in subjects with schizophrenia, while larger spines are ret

261 ation of TSP-1 is significantly increased in subjects with scleroderma following PAH development.

262 sis (3.0% vs. 6.1%; p < 0.001) compared with subjects with scores <2 (1.7% vs. 2.3%; p = 0.42; p valu

263 , tumor characteristics, and mortality among subjects with SD-CRC and with non-SD-CRC.

264 In subjects with SDB, levels of l-DLPFC GABA, but not Glx,

265 a large sample of resected lung tissues from subjects with severe COPD.

266 In subjects with severe hypoglycemia suitable for islet tra

267 and glycemic variability in type 1 diabetes subjects with severe hypoglycemia.

268 We now extend those findings to a cohort of subjects with sporadic ASD without any known mutations.

269 A subanalysis of 186 case subjects with sporadic IPF confirmed TERT, RTEL1, and PA

270 fit is seen in a real-world population among subjects with stable ischemic heart disease (SIHD) and a

271 d in a proof-of-concept clinical trial in 12 subjects with stable sickle cell disease.

272 bjects deviated most from the HP, especially subjects with surgical resection.

273 Subjects with susceptibility genotypes for celiac diseas

274 A total of 10 262 VFs from 1538 eyes of 909 subjects with suspect or manifest glaucoma and >/=5 VF e

275 , and results were unchanged after excluding subjects with suspected cirrhosis.

276 IR) neurons are decreased in the amygdala of subjects with SZ and BD.

277 The leading molecular pathways altered in subjects with SZ involved mitochondrial energy productio

278 etrads of unaffected comparison subjects and subjects with SZ, bipolar disorder, and major depressive

279 , transcriptome alterations were numerous in subjects with SZ, but rare in subjects with bipolar diso

280 l microscopy, that platelet-poor-plasma from subjects with T2D had a much greater propensity for hype

281 4.1 +/- 0.3, respectively) and threefold in subjects with T2DM (11.9 +/- 0.6; P < 0.001).

282 nd decreased in the remission group of obese subjects with T2DM after metabolic surgery.

283 phoblastoid B cell lines (LCLs) derived from subjects with TERT promoter mutations showed increased t

284 subjects with posterior cortical atrophy, 4 subjects with the logopenic variant of primary progressi

285 cts in mice with CF as well as in cells from subjects with the p.Phe508del mutation.

286 weight, respectively, compared with that of subjects with the smallest intake reductions (P < 0.001)

287 n a cohort of iron-replete, nonanemic female subjects with the use of a stable isotope ((57)Fe).Twelv

288 lities with a variety of perceptual tasks in subjects with treated amblyopia.

289 9(+) lymphocyte populations isolated from 81 subjects with type 1 diabetes (T1D).

290 T cells from subjects with type 1 diabetes also exhibited lower intra

291 set of genetic variants in larger numbers of subjects with type 1 diabetes characterized for a wider

292 Elevated T cell MHP was not detected in subjects with type 2 diabetes.

293 Clinical variables did not differ between subjects with type 2-high and type 2-low status.

294 ytokine responses may differentiate ECs from subjects with uncontrolled viral replication or from tho

295 ected HLA-DR7(+) long-term nonprogressor HIV subjects with undetectable HCMV plasma viremia.

296 Including 140 subjects with variable viral loads and measuring the pla

297 say affected tissue from a diverse cohort of subjects with vascular anomalies with overgrowth.

298 onvalescent samples (P </= .002) and control subjects with venom allergy (P < .0001).

299 e the difference in NK cell activity between subjects with vs without CRC.

300 ntrolled diabetes (HbA1c 6.8% or higher) and subjects with well controlled diabetes (HbA1c less than